Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen) [NA]
A Danish clinical trial (SomaScreen) recruiting adults in outpatient psychiatric care to screen for somatic conditions, sponsored by Amager …
-
CLINICAL_TRIALS other · 2026-04-08Clinical Trial Update: Effects of Physical Training in Patients With Advanced Heart Failure [NA]
Clinical trial investigating the effects of physical training in patients with advanced heart failure; recruitment has not yet begun.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Primary Preventive Ventricular Tachycardia Ablation In High-Risk Patients Who Receive A Prophylactic Implantable Cardioverter Defibrillator [NA]
This entry notes an ongoing clinical trial evaluating primary preventive ventricular tachycardia ablation in high-risk heart failure patient…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Prospective Multicentric Study Comparing the Acute Hemodynamic Effect of Three Modes of Stimulation in Cardiac Resynchronization Therapy Recipients [NA]
A multicenter prospective study evaluating three stimulation modes in cardiac resynchronization therapy recipients was terminated.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission. [Phase 4]
This clinical trial update concerns a Phase 4 study examining down-titration of guideline-directed medical therapy in heart failure patients…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: DANHEART (H-HeFT and Met-HeFT) [Phase 4]
The DANHEART program's Phase 4 trials (H-HeFT and Met-HeFT) investigating heart failure in patients with diabetes have completed.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Pulmonary Artery Sensor System Pressure Monitoring to Improve Heart Failure (HF) Outcomes [NA]
This clinical trial update notes that a Pulmonary Artery Sensor System for pressure monitoring in heart failure is currently active but not …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy [Phase 1]
A Phase 1 clinical trial evaluating a second infusion of FAP iCDC for end-stage dilated cardiomyopathy, currently not recruiting.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE
A clinical trial at University Heart Center Freiburg - Bad Krozingen is studying multimodal phenotyping in patients referred for acute cardi…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation [Phase 3]
Phase 3 clinical trial evaluating ziltivekimab versus placebo in participants with heart failure and systemic inflammation; the study is cur…
-
CLINICAL_TRIALS other · 2026-04-07Clinical Trial Update: Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure [NA]
This clinical trial compares diuretic therapy alone to treatment with the Aortix Endovascular Device for acute heart failure and is currentl…
-
CLINICAL_TRIALS other · 2026-04-07Clinical Trial Update: AMEND-CRT: Mechanical Dyssynchrony as Selection Criterion for CRT [NA]
Clinical trial AMEND-CRT evaluates using mechanical dyssynchrony as a selection criterion for cardiac resynchronization therapy; the study i…
-
FDA approval · 2026-04-06FDA Approved: DAPAGLIFLOZIN — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin's original application for dapagliflozin tablets (generic), enabling market entry for the SGLT2 inhibitor.
-
FDA approval · 2026-04-06FDA Approved: DAPAGLIFLOZIN — Original Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s generic dapagliflozin (ANDA 211535) as an original application. The approval makes a generic version of dapagl…
-
FDA approval · 2026-04-06FDA Approved: DAPAGLIFLOZIN — Original Application (Ascend Laboratories, LLC)
FDA approved the original generic application for dapagliflozin, enabling a generic version of the SGLT2 inhibitor used for type 2 diabetes …
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy [Phase 1]
Phase 1 clinical trial assessing safety and efficacy of FAP iCDC in patients with end-stage dilated cardiomyopathy and heart failure; the st…
-
FDA approval · 2026-04-06FDA Approved: DAPAGLIFLOZIN — Original Application (Sandoz Inc)
FDA approves Sandoz's generic dapagliflozin under Original Application. The approval makes a generic version available for the same indicati…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Duke University-sponsored trial evaluating pharmacokinetics, pharmacodynamics, and safety of understudied drugs given to children as part of…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes [Phase 2]
A Phase 2 clinical trial evaluating sotagliflozin in patients with Type 1 diabetes mellitus and heart failure symptoms is currently recruiti…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Impact of Yoga on Cognitive Function [NA]
This entry reports an ongoing clinical trial evaluating the impact of yoga on cognitive function in individuals with heart failure and mild …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Randomized Clinical Trial to Improve Mobility After Hospitalization [NA]
Clinical trial update for an active-but-not-recruiting randomized study aiming to improve mobility after hospitalization, sponsored by the U…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Effect and Cost Effectiveness of a Dyadic Empowerment-based Heart Failure Management Program for Self-care [NA]
A clinical trial evaluating the effectiveness and cost-effectiveness of a dyadic, empowerment-based heart failure self-care management progr…
-
FDA approval · 2026-04-06FDA Approved: DAPAGLIFLOZIN — Original Application (Florida Pharmaceutical Products, LLC)
FDA approved the Original Application (ANDA) for dapagliflozin from Florida Pharmaceutical Products, LLC.
-
FDA approval · 2026-04-06FDA Approved: DAPAGLIFLOZIN — Original Application (Macleods Pharmaceuticals Limited)
FDA approves the generic dapagliflozin from Macleods Pharmaceuticals Limited under an Original Abbreviated New Drug Application (ANDA).
-
FDA approval · 2026-04-06FDA Approved: DAPAGLIFLOZIN — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original ANDA for dapagliflozin, enabling a generic version of the diabetes medication to rea…